Retinal Sensitivity in BRVO After Anti-VEGF Therapy

Status Recruiting

Clinical Trial Summary

The efficacy of anti-vascular endothelial growth factor (VEGF) therapy for branch retinal vein occlusion (BRVO) is shown, but its effect on retinal sensitivity is not fully investigated. The purpose of this study is to compare the changes in retinal sensitivity after ranibizumab therapy or combination therapy of ranibizumab and laser photocoagulation in eyes with BRVO.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02527733
Study type	Interventional
Source	Fukushima Medical University
Contact	Akira Ojima, M.D., Ph.D
Phone	+81-24-548-2111
Email	ao@fmu.ac.jp
Status	Recruiting
Phase	Phase 4
Start date	June 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02390245` - Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study	N/A
Active, not recruiting	`NCT04120311` - Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole	Phase 1
Not yet recruiting	`NCT04601688` - Branch Retinal Vein Occlusion (BRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only.	N/A
Completed	`NCT01968239` - Proof of Concept Study of Re-treatment in BRVO With Ranibizumab Guided by OCT	Phase 2
Completed	`NCT00612261` - Sheathotomy vs. Intravitreal Triamcinolone for Branch Retinal Vein Occlusion	N/A
Not yet recruiting	`NCT03637283` - Anti-VEGF Instead of Intraoperative Fan-shaped Photocoagulation in BRVO Combined With Vitreous Hemorrhage	N/A
Completed	`NCT01976338` - Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO)	Phase 3
Completed	`NCT01471691` - Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab	Phase 1/Phase 2
Completed	`NCT01247220` - REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab Study	Phase 2
Terminated	`NCT00642226` - Combined Vitrectomy and Triamcinolone in Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)	Phase 3
Terminated	`NCT05127525` - EffiCacy, Safety and ToLErability of a Novel Ocular ANtiseptic for Ocular Use (CLEAN)	Phase 3
Completed	`NCT01599650` - Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion	Phase 3
Active, not recruiting	`NCT04120636` - Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole	Phase 1
Recruiting	`NCT01975103` - Non-damaging Retinal Laser Therapy With PASCAL Laser for Macular Diseases	Phase 2
Recruiting	`NCT01348633` - Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human Eye	N/A
Completed	`NCT04740905` - A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion	Phase 3
Completed	`NCT01396057` - Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)	Phase 3
Terminated	`NCT03802630` - Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion	Phase 3
Completed	`NCT02478515` - Evaluation of the Usefulness of a PRN Regimen Using Ranibizumab for Macular Edema Due to Branch Retinal Vein Occlusion	Phase 4
Terminated	`NCT01795209` - Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair Vision	Phase 4